Vinaconex (VCG) Acquires 18% Stake in Aegis Medical for 180 Billion VND

Overview

Vinaconex (VCG) has approved a special transaction to acquire an 18% stake in Aegis Medical Company from its CEO and family members, estimated at 180 billion VND. The move is part of VCG’s strategy to diversify into healthcare, following the September 2025 groundbreaking of Aegis’s 4,500 billion VND international healthcare complex.

Key Facts

• Vinaconex (VCG) approved the acquisition of 18 million shares, representing 18% of Aegis Medical’s charter capital.
• The sellers are CEO Nguyen Xuan Dong (10 million shares), his wife Do Thi Thanh (4.8 million shares), and their son Nguyen Xuan Tung (3.2 million shares).
• The transaction is estimated at 180 billion VND, based on Aegis Medical’s charter capital of 1,000 billion VND as of September 2025.
• Aegis Medical is the developer of the Aegis International Healthcare Complex, a 4,500 billion VND project that Vinaconex began constructing in September 2025.
• For 2026, Vinaconex targets revenue of 15,423 billion VND and after-tax profit of 1,037 billion VND, down 23% and 73% respectively from 2025.
• VCG plans to issue over 51.7 million additional shares to raise charter capital to approximately 6,981 billion VND.
• VCG shares closed at 22,000 VND on April 15, 2026, down 1.53% with volume of 10,997,200 shares.

What Happened

Vinaconex’s Board of Directors issued Resolution No. 02/2026 approving the acquisition of 18 million shares in Aegis Medical Company from three individuals: CEO Nguyen Xuan Dong, his wife Do Thi Thanh, and their son Nguyen Xuan Tung. The transaction is expected to close in April 2026.

Aegis Medical, with a charter capital of 1,000 billion VND, is the developer of the Aegis International Healthcare Complex, a 4,500 billion VND project that Vinaconex began constructing in September 2025. The acquisition aligns with Vinaconex’s strategy to expand into non-construction sectors.

Market Context

Vinaconex (VCG), listed on HOSE, closed at 22,000 VND on April 15, 2026, down 1.53% on volume of 11 million shares. The stock has been under pressure amid a broader market downturn and VCG’s weak 2026 guidance, which forecasts a 73% drop in net profit. The healthcare acquisition may be seen as a long-term diversification play, but near-term earnings headwinds remain.

Strategic Significance

The acquisition of an 18% stake in Aegis Medical gives Vinaconex a foothold in Vietnam’s growing healthcare sector, complementing its core construction business. The Aegis International Healthcare Complex, which Vinaconex is already building, represents a significant long-term asset. This move is part of VCG’s broader multi-sector investment strategy, which also includes a planned share issuance to raise capital for further diversification. However, the 2026 profit guidance suggests near-term challenges from its core construction operations.

What to Watch

• Completion of the Aegis Medical stake transfer in April 2026.
• VCG’s Q1 2026 earnings report to assess revenue and profit trends.
• Progress of the Aegis International Healthcare Complex construction and any operational updates.
• Shareholder approval and execution of the 51.7 million share issuance plan.
• Any further acquisitions or divestitures as part of VCG’s multi-sector strategy.